Label Changes for:

Priftin(rifapentine) tablets

July 2010

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2010

USE IN SPECIFIC POPULATIONS

Pediatric Use
  • In a pharmacokinetic study conducted in 2 to 12 year-old pediatric patients, the exposure to rifapentine (i.e., AUC and Cmax observed in healthy adults.

Hide
(web4)